Higher anticancer effects were obtained by developed liposomal curcumin powder than the other two tested medications in terms of pathology and the expression of various cancer-related markers such as VEGF, malondialdehyde, TNF-α, caspase-3, and BCL-2. The gene discussed is BCL2; the disease is cancer.